STRS Ohio’s Ginkgo Bioworks DNA Stock Holding History

STRS Ohio’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,000	Closed	-$43.7K	–	2202
2025 Q3	$43.7K	Buy	+3,000	New	+$35.9K	﹤0.01%	2028

Other funds holding DNA

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

STRS Ohio's DNA Position: Q4 2025 in Review

STRS Ohio sold out of Ginkgo Bioworks (DNA) in Q4 2025, closing a stake of 3,000 shares — an estimated $43.7K sold.

STRS Ohio first reported a position in DNA in Q3 2025 and held it in 1 quarter. The position peaked at $43.7K in Q3 2025. 181 funds tracked by Wall St. Rank hold DNA as of Q4 2025.

STRS Ohio reported no remaining Ginkgo Bioworks position as of Q4 2025 after selling out during the quarter.
STRS Ohio sold 3,000 Ginkgo Bioworks shares in Q4 2025, an estimated $43.7K.
STRS Ohio first reported a position in Ginkgo Bioworks in Q3 2025 and held it in 1 quarter.
STRS Ohio's Ginkgo Bioworks position peaked at $43.7K in Q3 2025.
181 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2025.

Based on STRS Ohio's 13F filing for Q4 2025, filed 2 Feb 2026.